Hrt Financial LP Belite Bio, Inc Transaction History

Hrt Financial LP

$12.8 Billion
Q1 2025

A detailed history of Hrt Financial LP transactions in Belite Bio, Inc stock. As of the latest transaction made, Hrt Financial LP holds 4,117 shares of BLTE stock, worth $265,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,117

Holding current value

$265,134

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 15, 2025	BUY	$53.04 - $69.5 $218,365 - $286,131	4,117 New	4,117 $272,000
Q2 2024 Aug 12, 2024	BUY	$32.33 - $50.1 $174,872 - $270,990	5,409 New	5,409 $247,000

Others Institutions Holding BLTE

# of Institutions

Shares Held

270K

Call Options Held

Put Options Held

Gamma Investing LLC Foster City, CA

122K
Shares

$7.89 Million
0.01% of portfolio
Alyeska Investment Group, L.P. Chicago, IL

83.6K
Shares

$5.39 Million
0.02% of portfolio
State Street Corp Boston, MA

20.1K
Shares

$1.29 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

12.8K
Shares

$821,293
0.0% of portfolio
Jpmorgan Chase & CO New York, NY

8.16K
Shares

$525,632
0.0% of portfolio

View Full List

About BELITE BIO, INC

Ticker BLTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,867,400
Market Cap $1.6B
Description
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...

More about BLTE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account